Insiders · Profile

Piacquad David

SVP, Business Development at Amgen. Filing since 6 Feb 2020. CIK 0001602343

Company

Date

Role

Action

Amount

Of holding

6 Feb 2020

SVP, Business Development

Sold, plan not stated

9,264

$2.13M

18.9%

1 decision on file.